The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. TELA Bio Inc shares valued at $4,000,440 were purchased by EW HEALTHCARE PARTNERS FUND 2, on Nov 17 ’25. At $1.11 per share, EW HEALTHCARE PARTNERS FUND 2, acquired 3,604,000 shares. The insider’s holdings grew to 7,714,709 shares worth approximately $8.64 million following the completion of this transaction.
As published in a research note from Piper Sandler on March 21, 2025, TELA Bio Inc [TELA] has been rated down from an Overweight to a Neutral and the price target has been revised to $2 from $5. Analysts at Lake Street started covering the stock with ‘”a Buy”‘ outlook in a report released in late May. As of December 03, 2019, Piper Jaffray has initiated its “an Overweight” rating for TELA. Earlier on December 03, 2019, JMP Securities initiated its rating. Their recommendation was “a Mkt outperform” for TELA stock.
Analyzing TELA Stock Performance
On last trading session, TELA Bio Inc [NASDAQ: TELA] plunged -1.75% to $1.12. The stock’s lowest price that day was $1.12, but it reached a high of $1.19 in the same session. During the last five days, there has been a surge of approximately 3.70%. Over the course of the year, TELA Bio Inc shares have dropped approximately -62.79%. Shares of the company reached a 52-week high of $3.0994 on 01/02/25 and a 52-week low of $0.8645 on 04/08/25.
Support And Resistance Levels for TELA Bio Inc (TELA)
According to the 24-hour chart, there is a support level at 1.0967, which, if violated, would cause prices to drop to 1.0733. In the upper region, resistance lies at 1.1667. The next price resistance is at 1.2133. RSI (Relative Strength Index) is 41.34 on the 14-day chart, showing neutral technical sentiment.
Is TELA Bio Inc subject to short interest?
Stocks of TELA Bio Inc saw a sharp steep in short interest on 2025-11-14 dropping by 7222.0 shares to 0.42 million. Data from Yahoo Finance shows that the short interest on 2025-10-15 was 0.42 million shares. A decline of -1.73% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 2.45 of the overall float, the days-to-cover ratio (short ratio) decline to 2.45.
Which companies own the most shares of TELA Bio Inc (TELA)?
In terms of TELA Bio Inc share price expectations, FactSet research, analysts set an average price target of 1.25 in the next 12 months, up nearly 9.65% from the previous closing price of $1.14. Analysts anticipate TELA Bio Inc stock to reach 1.25 by 2025, with the lowest price target being 1.25. In spite of this, 2 analysts ranked TELA Bio Inc stock as Buy at the end of 2025.
